What the company does
Kamada Ltd. manufactures and sells plasma-derived protein therapeutics. Its products include KAMRAB/KEDRAB indicated as prophylaxis of rabies; CYTOGAM for prophylaxis of Cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplants; VARIZIG for post exposure prophylaxis of varicella; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis; GLASSIA for intravenous AATD; KAMRHO (D) IM for prophylaxis of hemolytic disease of newborns; and Echis coloratus and Vipera palaestinae Antiserum to treat snake bite. The company also distributes biopharmaceutical products in …
What the weekly tape is saying
KMDA closed the latest completed week at 2,175 ILA. The 4-week return is -7.3% and the 12-week return is -19.0%. Trend Signal is inactive, Market Dynamics is -1.27. Setup signature: Risk-first tape with a 19/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 2,458 ILA
- Vs Trend Line
- -11.5%
- Fair Value
- 2,236 ILA
- Vs Fair Value
- -2.7%
- 52W High
- 2,889 ILA
- 52W Low
- 1,955 ILA
- Drawdown
- -24.7%
- Range Position
- 23.5%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 15
- 52W Active Breadth
- 28.8%
- Sector Scope
- IL Healthcare
- Sector Rank
- 14 of 51
- Sector Percentile
- 74.0%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
IL Healthcare
- Tracked Peers
- 51
- 4W Rank
- 37 of 51
- Avg 1W
- -0.8%
- Avg 4W
- 1587.1%
- Trend Breadth
- 29.4%
- Positive MD
- 52.9%
IL Drug Manufacturers - Specialty & Generic
- Tracked Peers
- 13
- 4W Rank
- 9 of 13
- Avg 1W
- 1.6%
- Avg 4W
- 1915.1%
- Trend Breadth
- 30.8%
- Positive RS
- 15.4%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -1.27
- 4W MD Change
- -48.9%
- Relative Strength
- -26.28
- 4W RS Change
- -7.2%
- Expectation
- Undecided
- Probability
- 46.23%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 146.5K
- 13W Average
- 257.6K
- 52W Average
- 300.2K
- Vs 13W
- 0.6x
- Vs 52W
- 0.5x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 2.7%
- 52W Volatility
- 3.9%
- Upside Weeks
- 22
- Downside Weeks
- 29
- Downside Breadth
- 55.8%
- Avg Gain / Loss
- 3.5% / -2.9%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- TLV
- Country
- IL
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- ILA
- Market Cap
- 1.2B
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 2,175 ILA | 0.8% | 2,458 ILA | 2,236 ILA | -1.27 | -26.28 | 146.5K | Off |
| 5 Jun 2026 | 2,157 ILA | -2.6% | 2,463 ILA | 2,235 ILA | -1.05 | -26.45 | 290.5K | Off |
| 29 May 2026 | 2,214 ILA | -3.3% | 2,463 ILA | 2,233 ILA | -0.91 | -28.39 | 327.7K | Off |
| 22 May 2026 | 2,289 ILA | -2.5% | 2,465 ILA | 2,230 ILA | -0.88 | -25.71 | 265.4K | Off |
| 15 May 2026 | 2,347 ILA | -5.9% | 2,463 ILA | 2,229 ILA | -0.85 | -24.52 | 596.2K | Off |
| 8 May 2026 | 2,494 ILA | 2.8% | 2,458 ILA | 2,225 ILA | -0.93 | -22.95 | 275.6K | On |
| 1 May 2026 | 2,427 ILA | -0.7% | 2,450 ILA | 2,220 ILA | -0.80 | -24.32 | 176.3K | On |
| 24 Apr 2026 | 2,444 ILA | -2.3% | 2,446 ILA | 2,216 ILA | -0.52 | -23.49 | 204.3K | On |
| 17 Apr 2026 | 2,502 ILA | -3.5% | 2,439 ILA | 2,211 ILA | -0.27 | -23.25 | 208.1K | On |
| 10 Apr 2026 | 2,592 ILA | 0.0% | 2,433 ILA | 2,206 ILA | 0.21 | -22.00 | 103.3K | On |
| 3 Apr 2026 | 2,592 ILA | 2.7% | 2,425 ILA | 2,200 ILA | 0.61 | -18.02 | 221.2K | On |
| 27 Mar 2026 | 2,523 ILA | -6.0% | 2,417 ILA | 2,194 ILA | 0.96 | -19.19 | 321.6K | On |
| 20 Mar 2026 | 2,685 ILA | -2.0% | 2,410 ILA | 2,189 ILA | 1.34 | -19.11 | 211.4K | On |
| 13 Mar 2026 | 2,741 ILA | -2.2% | 2,400 ILA | 2,182 ILA | 1.46 | -15.49 | 364.9K | On |